GSK’s Blenrep shows significant efficacy in DREAMM-7 trial in multiple myeloma

GSK plc has unveiled promising results from the DREAMM-7 phase III trial, which highlights a notable advancement in the treatment of relapsed or refractory multiple ... Read More